Company intelligence / Profile preview

Meneldor

Ownership: Private
Development stage: Phase 2

Overview

Meneldor is a Dutch venture capital investment firm focused on early-stage biotech and pharmaceutical companies developing new biological or chemical molecular entities that address significant unmet medical needs. The firm conducts thorough scientific and business due diligence before investing. It typically invests alongside specialists and invites co-investors to participate in selected opportunities. Portfolio companies are generally in preclinical through Phase 2 stages of development.

Modalities: Small moleculeBiologicChemical molecular entityBiological molecular entity
Industry: Investors

Partnerships

Co-investments with other venture funds such as High-Tech Gründerfondspartnerships with academic institutions via portfolio companies' activities

Beyond the preview

Go deeper on Meneldor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meneldor.

Explore the full profile